曲伐沙星对557株厌氧菌的体外活性
In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.
作者信息
Wexler H M, Molitoris E, Molitoris D, Finegold S M
机构信息
Medical Services, Veterans Administration Medical Center, West Los Angeles, California 90073, USA.
出版信息
Antimicrob Agents Chemother. 1996 Sep;40(9):2232-5. doi: 10.1128/AAC.40.9.2232.
Abstract
The antimicrobial activity of trovafloxacin for 557 strains of anaerobic bacteria was determined by the National Committee for Clinical Laboratory Standards-approved Wadsworth agar dilution technique. The species tested included Bacteroides fragilis (n = 91), other members of the B. fragilis group (n = 130), Campylobacter gracilis (n = 15), other Bacteroides spp. (n = 16), Prevotella spp. (n = 49), Porphyromonas spp. (n = 15), Fusobacterium spp. (n = 62), Bilophila wadsworthia (n = 24), Sutterella wadsworthensis (n = 21), Clostridium spp. (n = 61), Peptostreptococcus spp. (n = 38), and gram-positive non-spore-forming rods (n = 35). Trovafloxacin inhibited all strains of B. fragilis at < or = 0.5 microgram/ml, 99% of other B. fragilis group species at < or = 2 micrograms/ml, and 96% of all anaerobes tested at < or = 2 micrograms/ml.
摘要
采用美国国家临床实验室标准委员会认可的沃兹沃思琼脂稀释技术，测定了曲伐沙星对557株厌氧菌的抗菌活性。所检测的菌种包括脆弱拟杆菌（n = 91）、脆弱拟杆菌群的其他成员（n = 130）、纤细弯曲菌（n = 15）、其他拟杆菌属菌种（n = 16）、普雷沃菌属菌种（n = 49）、卟啉单胞菌属菌种（n = 15）、梭杆菌属菌种（n = 62）、沃兹沃思嗜胆菌（n = 24）、沃兹沃思萨特菌（n = 21）、梭菌属菌种（n = 61）、消化链球菌属菌种（n = 38）以及革兰氏阳性无芽孢杆菌（n = 35）。曲伐沙星对所有脆弱拟杆菌菌株的最低抑菌浓度≤0.5微克/毫升，对99%的其他脆弱拟杆菌群菌种的最低抑菌浓度≤2微克/毫升，对96%的所有受试厌氧菌的最低抑菌浓度≤2微克/毫升。
相似文献
1
In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.曲伐沙星对557株厌氧菌的体外活性
Antimicrob Agents Chemother. 1996 Sep;40(9):2232-5. doi: 10.1128/AAC.40.9.2232.
2
In vitro activity of Bay Y3118 against anaerobic bacteria.Bay Y3118对厌氧菌的体外活性。
Antimicrob Agents Chemother. 1993 Nov;37(11):2509-13. doi: 10.1128/AAC.37.11.2509.
3
Activities of gemifloxacin (SB 265805, LB20304) compared to those of other oral antimicrobial agents against unusual anaerobes.与其他口服抗菌药物相比，吉米沙星（SB 265805，LB20304）对罕见厌氧菌的活性。
Antimicrob Agents Chemother. 1999 Nov;43(11):2726-30. doi: 10.1128/AAC.43.11.2726.
4
In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteria.克林沙星（CI-960）和PD 131628-2对厌氧菌的体外活性
J Antimicrob Chemother. 1994 Oct;34(4):579-84. doi: 10.1093/jac/34.4.579.
5
Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria.莫西沙星体外对专性厌氧菌的比较活性
Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):228-32. doi: 10.1007/s100960050465.
6
In vitro activity of gemifloxacin (SB 265805) against anaerobes.吉米沙星（SB 265805）对厌氧菌的体外活性。
Antimicrob Agents Chemother. 1999 Sep;43(9):2231-5. doi: 10.1128/AAC.43.9.2231.
7
Comparative in vitro activities of trovafloxacin (CP 99,219) and other antimicrobials against clinically significant anaerobes.曲伐沙星（CP 99,219）与其他抗菌药物对临床重要厌氧菌的体外活性比较
Antimicrob Agents Chemother. 1997 Feb;41(2):484-7. doi: 10.1128/AAC.41.2.484.
8
In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria.新型去氟（6）喹诺酮类药物加替沙星对临床厌氧菌的体外活性
Antimicrob Agents Chemother. 2003 Nov;47(11):3667-71. doi: 10.1128/AAC.47.11.3667-3671.2003.
9
In vitro activities of three of the newer quinolones against anaerobic bacteria.三种新型喹诺酮类药物对厌氧菌的体外活性
Antimicrob Agents Chemother. 1992 Jan;36(1):239-43. doi: 10.1128/AAC.36.1.239.
10
Synergic activity, for anaerobes, of trovafloxacin with clindamycin or metronidazole: chequerboard and time-kill methods.
J Antimicrob Chemother. 2000 May;45(5):633-8. doi: 10.1093/jac/45.5.633.
引用本文的文献
1
The new fluoroquinolones: A critical review.新型氟喹诺酮类药物：批判性综述。
Can J Infect Dis. 1999 May;10(3):207-38. doi: 10.1155/1999/378394.
2
In vitro antianaerobic activity of DX-619, a new des-fluoro(6) quinolone.新型去氟（6）喹诺酮DX-619的体外抗厌氧活性
Antimicrob Agents Chemother. 2006 Nov;50(11):3908-13. doi: 10.1128/AAC.00639-06.
3
Antianaerobic activity of a novel fluoroquinolone, WCK 771, compared to those of nine other agents.新型氟喹诺酮类药物WCK 771与其他九种药物的抗厌氧活性比较。
Antimicrob Agents Chemother. 2004 Aug;48(8):3188-92. doi: 10.1128/AAC.48.8.3188-3192.2004.
4
In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria.新型去氟（6）喹诺酮类药物加替沙星对临床厌氧菌的体外活性
Antimicrob Agents Chemother. 2003 Nov;47(11):3667-71. doi: 10.1128/AAC.47.11.3667-3671.2003.
5
Antibiotic resistance in bacteria isolated from subgingival plaque in a norwegian population with refractory marginal periodontitis.从患有难治性边缘性牙周炎的挪威人群龈下菌斑中分离出的细菌的抗生素耐药性。
Antimicrob Agents Chemother. 2003 Apr;47(4):1443-6. doi: 10.1128/AAC.47.4.1443-1446.2003.
6
Activities of garenoxacin (BMS-284756) and other agents against anaerobic clinical isolates.加雷沙星（BMS-284756）及其他药物对厌氧临床分离株的活性。
Antimicrob Agents Chemother. 2003 Mar;47(3):910-6. doi: 10.1128/AAC.47.3.910-916.2003.
7
In vitro activities of a new des-fluoroquinolone, BMS 284756, and seven other antimicrobial agents against 151 isolates of Eikenella corrodens.新型去氟喹诺酮类药物BMS 284756与其他七种抗菌药物对151株腐蚀艾肯菌的体外活性
Antimicrob Agents Chemother. 2002 Apr;46(4):1141-3. doi: 10.1128/AAC.46.4.1141-1143.2002.
8
Comparative antianaerobic activity of BMS 284756.BMS 284756的抗厌氧活性比较
Antimicrob Agents Chemother. 2001 Feb;45(2):589-92. doi: 10.1128/AAC.45.2.589-592.2001.
9
Comparative in vitro activities of clinafloxacin and trovafloxacin against 1,000 isolates of bacteroides fragilis group: effect of the medium on test results.克林沙星与曲伐沙星对1000株脆弱拟杆菌属菌株的体外活性比较：培养基对试验结果的影响
Antimicrob Agents Chemother. 2000 Jun;44(6):1710-2. doi: 10.1128/AAC.44.6.1710-1712.2000.
10
In vitro activities of gatifloxacin, two other quinolones, and five nonquinolone antimicrobials against obligately anaerobic bacteria.加替沙星、另外两种喹诺酮类药物以及五种非喹诺酮类抗菌药物对专性厌氧菌的体外活性
Antimicrob Agents Chemother. 1999 Nov;43(11):2783-6. doi: 10.1128/AAC.43.11.2783.
本文引用的文献
1
Sutterella wadsworthensis gen. nov., sp. nov., bile-resistant microaerophilic Campylobacter gracilis-like clinical isolates.沃兹沃思萨特氏菌属，新属，新种，耐胆汁微需氧纤细弯曲菌样临床分离株。
Int J Syst Bacteriol. 1996 Jan;46(1):252-8. doi: 10.1099/00207713-46-1-252.
2
Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD 131628 and clinafloxacin.测试厌氧细菌对两种氟喹诺酮类化合物（PD 131628和克林沙星）敏感性的方法。
J Antimicrob Chemother. 1993 Jun;31(6):893-900. doi: 10.1093/jac/31.6.893.
3
In vitro activity of DU-6859a, a new fluorocyclopropyl quinolone.新型氟环丙基喹诺酮DU-6859a的体外活性
Antimicrob Agents Chemother. 1993 Dec;37(12):2747-53. doi: 10.1128/AAC.37.12.2747.
4
In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteria.克林沙星（CI-960）和PD 131628-2对厌氧菌的体外活性
J Antimicrob Chemother. 1994 Oct;34(4):579-84. doi: 10.1093/jac/34.4.579.
5
In vitro activity of DU-6859a against anaerobic bacteria.DU-6859a对厌氧菌的体外活性。
Antimicrob Agents Chemother. 1994 Oct;38(10):2504-9. doi: 10.1128/AAC.38.10.2504.
6
Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes.CP 99,219与环丙沙星、格帕沙星、甲硝唑、头孢西丁、哌拉西林及哌拉西林-他唑巴坦对489株厌氧菌的抗菌活性比较
Antimicrob Agents Chemother. 1994 Oct;38(10):2471-6. doi: 10.1128/AAC.38.10.2471.
7
Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.新型喹诺酮类药物Bay y 3118与环丙沙星、司帕沙星、妥舒沙星、CI-960和CI-990的体外活性比较
J Antimicrob Chemother. 1993 Apr;31(4):505-22. doi: 10.1093/jac/31.4.505.
8
Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals.喹诺酮类药物对社区医院分离出的厌氧菌的比较活性。
Antimicrob Agents Chemother. 1985 Apr;27(4):657-9. doi: 10.1128/AAC.27.4.657.
9
In-vitro and in-vivo potency of five new fluoroquinolones against anaerobic bacteria.五种新型氟喹诺酮类药物对厌氧菌的体外和体内抗菌效能
J Antimicrob Chemother. 1986 Dec;18(6):693-701. doi: 10.1093/jac/18.6.693.
10
The antibiotic sensitivity of the Bacteroides fragilis group in the United Kingdom.英国脆弱拟杆菌群的抗生素敏感性
J Antimicrob Chemother. 1987 Oct;20(4):477-88. doi: 10.1093/jac/20.4.477.
Zotero 插件